Erik Sims
Corporate Officer/Principal at OCUPHIRE PHARMA, INC.
Erik Sims active positions
| Companies | Position | Start | End |
|---|---|---|---|
| OCUPHIRE PHARMA, INC. | Corporate Officer/Principal | 31/05/2023 | - |
| Comptroller/Controller/Auditor | 31/03/2021 | 30/05/2023 |
Career history of Erik Sims
Former positions of Erik Sims
| Companies | Position | Start | End |
|---|---|---|---|
| NEUROBO PHARMACEUTICALS, INC. | Corporate Officer/Principal | 31/12/2015 | - |
Training of Erik Sims
| Walsh College | Masters Business Admin |
| University of Michigan-Flint | Undergraduate Degree |
Statistics
International
| United States | 5 |
Operational
| Corporate Officer/Principal | 2 |
| Comptroller/Controller/Auditor | 1 |
| Masters Business Admin | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| OCUPHIRE PHARMA, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Gemphire Therapeutics, Inc.
 Gemphire Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Gemphire Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics of dyslipidemia, as well as non-alcoholic fatty liver disease. It offers a small molecule formulated as a tablet product under the Gemcabene brand. The company was founded by Charles L. Bisgaier and David Lowenschuss on October 30, 2014 and is headquartered in Livonia, MI. | Health Technology |
- Stock Market
- Insiders
- Erik Sims
- Experience
